Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab

Published:2023-10 Issue:10 Volume:21 Page:2776-2783
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Bou-Jaoudeh Melissa,Mimoun Angelina,Delignat Sandrine,Peyron Ivan,Capdevila Ladislas,Daventure Victoria,Deligne Claire,Dimitrov Jordan D.,Christophe Olivier D.,Denis Cécile V.,Lenting Peter J.,Proulle Valérie,Lacroix-Desmazes Sébastien

Funder

Bayer Healthcare

Spark Therapeutics Inc

European Union

Agence nationale de la recherche

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Factor VIII–mimetic function of humanized bispecific antibody in hemophilia A;Shima;N Engl J Med,2016

2. The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 study;Oldenburg;Haemophilia,2019

3. Emicizumab prophylaxis in patients who have hemophilia A without inhibitors;Mahlangu;N Engl J Med,2018

4. Emicizumab prophylaxis in hemophilia A with inhibitors;Oldenburg;N Engl J Med,2017

5. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study;Astermark;Blood,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies;HemaSphere;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP